Liver tumor models in transgenic zebrafish: an alternative in vivo approach to study hepatocarcinogenes

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Hawkins WE, Overstreet RM, Fournie JW, Walker WW. Development of aquarium fish models for environmental carcinogenesis: tumor induction in seven species. J. Appl. Toxicol.5(4),261–264 (1985).
  Medline CASGoogle Scholar
• 2  Spitsbergen JM, Kent ML. The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations. Toxicol. Pathol.31(Suppl.),62–87 (2003).
  Medline CASGoogle Scholar
• 3  Spitsbergen JM, Tsai HW, Reddy A et al. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N’-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol. Pathol.28(5),716–725 (2000).▪ A representative study of using a chemical carcinogen to induce zebrafish tumors, which demonstrates the histopathological similarity of fish and human tumors, and thus lays a fundation for the use of zebrafish as a human cancer model.
  Medline CASGoogle Scholar
• 4  Spitsbergen JM, Tsai HW, Reddy A et al. Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol. Pathol.28(5),705–715 (2000).
  Medline CASGoogle Scholar
• 5  Mizgireuv IV, Majorova IG, Gorodinskaya VM, Khudoley VV, Revskoy SY. Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio). Toxicol. Pathol.32(5),514–518 (2004).
  Medline CASGoogle Scholar
• 6  Lam SH, Wu YL, Vega VB et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat. Biotechnol.24(1),73–75 (2006).
  Medline CASGoogle Scholar
• 7  Ung CY, Lam SH, Gong Z. Comparative transcriptome analyses revealed conserved biological and transcription factor target modules between the zebrafish and human tumors. Zebrafish6(4),425–431 (2009).
  Medline CASGoogle Scholar
• 8  Gong ZY, Koh CHV, Nguyen AT et al. The zebrafish model for liver carcinogenesis. In: Molecular Genetics of Liver Neoplasia. Wang X, Grisham J, Thorgeirsson S (Eds). Springer, NY, USA, 197–217 (2010).
  Google Scholar
• 9  Jessen JR, Jessen TN, Vogel SS, Lin S. Concurrent expression of recombination activating genes 1 and 2 in zebrafish olfactory sensory neurons. Genesis29(4),156–162 (2001).
  Medline CASGoogle Scholar
• 10  Langenau DM, Traver D, Ferrando AA et al. Myc-induced T cell leukemia in transgenic zebrafish. Science299(5608),887–890 (2003).▪ First tumor model using transgenic zebrafish. Broadens the choice of animal models in human cancer studies.
  Medline CASGoogle Scholar
• 11  Yang HW, Kutok JL, Lee NH et al. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res.64(20),7256–7262 (2004).
  Medline CASGoogle Scholar
• 12  Park SW, Davison JM, Rhee J, Hruban RH, Maitra A, Leach SD. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology134(7),2080–2090 (2008).
  MedlineGoogle Scholar
• 13  Langenau DM, Keefe MD, Storer NY et al. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev.21(11),1382–1395 (2007).
  Medline CASGoogle Scholar
• 14  Patton EE, Widlund HR, Kutok JL et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol.15(3),249–254 (2005).
  Medline CASGoogle Scholar
• 15  Ceol CJ, Houvras Y, Jane-Valbuena J et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature471(7339),513–517 (2011).
  Medline CASGoogle Scholar
• 16  White RM, Cech J, Ratanasirintrawoot S et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature471(7339),518–522 (2011).
  Medline CASGoogle Scholar
• 17  Lister JA, Robertson CP, Lepage T, Johnson SL, Raible DW. nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development126(17),3757–3767 (1999).
  Medline CASGoogle Scholar
• 18  White RM, Sessa A, Burke C et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell2(2),183–189 (2008).
  Medline CASGoogle Scholar
• 19  Banerjee D, Harfouche R, Sengupta S. Nanotechnology-mediated targeting of tumor angiogenesis. Vascular Cell3(1),3 (2011).
  Medline CASGoogle Scholar
• 20  Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol.248(2),307–318 (2002).
  Medline CASGoogle Scholar
• 21  Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl Acad. Sci. USA104(44),17406–17411 (2007).
  Medline CASGoogle Scholar
• 22  Stoletov K, Kato H, Zardouzian E et al. Visualizing extravasation dynamics of metastatic tumor cells. J. Cell Sci.123(Pt 13),2332–2341 (2010).
  Medline CASGoogle Scholar
• 23  Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development132(23),5199–5209 (2005).
  Medline CASGoogle Scholar
• 24  Zhao C, Wang X, Zhao Y et al. A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS ONE6(7),E21768 (2011).
  Medline CASGoogle Scholar
• 25  Zhang S, Cao Z, Tian H et al. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.Clin. Cancer Res.17(13),4439–4450 (2011).
  Medline CASGoogle Scholar
• 26  Villanueva A, Minguez B, Forner A, Reig M, Llovet JM. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Ann. Rev. Med.61,317–328 (2010).
  Medline CASGoogle Scholar
• 27  Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol.14(27),4300–4308 (2008).
  MedlineGoogle Scholar
• 28  Lu JW, Hsia Y, Tu HC et al. Liver development and cancer formation in zebrafish. Birth Defects Res. C Embryo Today93(2),157–172 (2011).
  Medline CASGoogle Scholar
• 29  Vucur M, Roderburg C, Bettermann K et al. Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma? Oncotarget1(5),373–378 (2010).
  MedlineGoogle Scholar
• 30  Ingham PW. The power of the zebrafish for disease analysis. Hum. Mol. Genet.18(R1),R107–R112 (2009).
  Medline CASGoogle Scholar
• 31  Kari G, Rodeck U, Dicker AP. Zebrafish: an emerging model system for human disease and drug discovery. Clin. Pharmacol. Ther.82(1),70–80 (2007).
  Medline CASGoogle Scholar
• 32  Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet.8(5),353–367 (2007).
  Medline CASGoogle Scholar
• 33  Lam SH, Gong ZY. Fish as a model for human disease. In: Human Genetics (4th Edition). Vogel F, Motulsky AG (Eds). Springer Verlag, Heidelberg, Germany, 827–843 (2010).
  Google Scholar
• 34  Feitsma H, Cuppen E. Zebrafish as a cancer model. Mol. Cancer Res.6(5),685–694 (2008).
  Medline CASGoogle Scholar
• 35  Stoletov K, Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene27(33),4509–4520 (2008).
  Medline CASGoogle Scholar
• 36  Sukardi H, Chng HT, Chan EC, Gong Z, Lam SH. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opin. Drug Metab. Toxicol.7(5),579–589 (2011).
  Medline CASGoogle Scholar
• 37  Evensen L, Link W, Lorens JB. Imaged-based high-throughput screening for anti-angiogenic drug discovery. Curr. Pharm. Des.16(35),3958–3963 (2010).
  Medline CASGoogle Scholar
• 38  Rubinstein AL, Tran TC, Sneed B et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res.67(23),11386–11392 (2007).▪ First automated and quantitative screening assay developed specifically for zebrafish drug screen studies.
  MedlineGoogle Scholar
• 39  Chen S, Zhu Y, Xia W, Xia S, Xu X. Automated analysis of zebrafish images for phenotypic changes in drug discovery. J. Neurosci. Methods200(2),229–236 (2011).
  MedlineGoogle Scholar
• 40  Nguyen AT, Emelyanov A, Koh CH et al. A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish. Dis. Models Mech.4(6),801–813 (2011).▪▪ First hepatocellular carcinoma (HCC) model driven by oncogene overexpression in the zebrafish, demonstrating the feasibility of generation of zebrafish HCC by high levels of expression of a single oncogene.
  Medline CASGoogle Scholar
• 41  Zender L, Spector MS, Xue W et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell125(7),1253–1267 (2006).
  Medline CASGoogle Scholar
• 42  Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology140(5),1410–1426 (2011).
  Medline CASGoogle Scholar
• 43  Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol.9(7),517–531 (2008).
  Medline CASGoogle Scholar
• 44  Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA89(12),5547–5551 (1992).
  Medline CASGoogle Scholar
• 45  Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl Acad. Sci. USA97(14),7963–7968 (2000).
  Medline CASGoogle Scholar
• 46  Emelyanov A, Parinov S. Mifepristone-inducible LexPR system to drive and control gene expression in transgenic zebrafish. Dev. Biol.320(1),113–121 (2008).
  Medline CASGoogle Scholar
• 47  Li Z, Huang X, Zhan H et al. Inducible and repressable oncogenic-addicted hepatocellular carcinoma in Tet-On xmrk transgenic zebrafish. J. Hepatol.doi:10.1016/j.jhep.2011.07.025 (2011) (Epub ahead of print).▪▪ Inducible HCC model using transgenic zebrafish, demonstrating its potential in studying tumor initiation, progression and regression.
  Google Scholar
• 48  Schartl M. Homology of melanoma-inducing loci in the genus Xiphophorus. Genetics126(4),1083–1091 (1990).
  Medline CASGoogle Scholar
• 49  Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Parinov S, Gong Z. An inducible kras V12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Dis. Model Mech.doi:10.1242/dmm.008367 (2011) (Epub ahead of print).
  Google Scholar
• 50  Weinstein IB. Cancer. Addiction to oncogenes – the Achilles heal of cancer. Science297(5578),63–64 (2002).
  Medline CASGoogle Scholar
• 51  Mirbahai L, Williams TD, Zhan H, Gong Z, Chipman JK. Comprehensive profiling of zebrafish hepatic proximal promoter CpG island methylation and its modification during chemical carcinogenesis. BMC Genomics12,3 (2011).
  Medline CASGoogle Scholar
• 52  Zon LI, Bowman TV. Swimming into the future of drug discovery: in vivo chemical screens in zebrafish. ACS Chem. Biol.5(2),159–161 (2010).
  MedlineGoogle Scholar
• 53  North TE, Goessling W, Walkley CR et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature447(7147),1007–1011 (2007).▪ First example of using zebrafish to identify potential drug, which is later used in a clinical trial.
  Medline CASGoogle Scholar
• 54  Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA103(41),15166–15171 (2006).
  Medline CASGoogle Scholar
• 55  Chen J, Jette C, Kanki JP, Aster JC, Look AT, Griffin JD. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia21(3),462–471 (2007).
  MedlineGoogle Scholar
• 56  Zhuravleva J, Paggetti J, Martin L et al. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br. J. Haematol.143(3),378–382 (2008).
  Medline CASGoogle Scholar
• 57  Dovey M, White RM, Zon LI. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish6(4),397–404 (2009).
  Medline CASGoogle Scholar
• 58  Ju B, Spitsbergen J, Eden CJ, Taylor MR, Chen W. Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Mol. Cancer8,40 (2009).
  MedlineGoogle Scholar
• 59  Chen YH, Wang YH, Yu TH, Wu HJ, Pai CW. Transgenic zebrafish line with over-expression of Hedgehog on the skin: a useful tool to screen Hedgehog-inhibiting compounds. Transgenic Res.18(6),855–864 (2009).
  Medline CASGoogle Scholar
• 60  Santoriello C, Gennaro E, Anelli V et al. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS ONE5(12),e15170 (2010).
  MedlineGoogle Scholar
• 61  Liu NA, Jiang H, Ben-Shlomo A et al. Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc. Natl Acad. Sci. USA108(20),8414–8419 (2011).
  Medline CASGoogle Scholar
• 62  Gutierrez A, Grebliunaite R, Feng H et al. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J. Exp. Med.208(8),1595–1603 (2011).
  Medline CASGoogle Scholar
• 63  Korzh V, Korzh S, Pan XF et al. Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish. BMC Dev. Biol.8,84 (2008).
  MedlineGoogle Scholar